Bullish Signal: Sun Pharma, Dabur, Pidilite Recommended for Monday Buy

A market analyst, Sumeet Bagadia, has identified Sun Pharma, Dabur, and Pidilite Industries as potential buy recommendations for Monday, May 18, 2026. This advice is based on technical analysis, noting bullish trends and improving volumes for these specific Indian-listed companies.

Such recommendations from analysts can influence short-term trading sentiment and volume, especially for retail investors and day traders. For the Indian market, it highlights specific large-cap stocks within the defensive pharma and FMCG sectors that are showing technical strength, potentially attracting fresh capital.

Sun Pharmaceutical Industries (SUNPHARMA) could see increased buying interest as it approaches its 1960 resistance. Dabur India (DABUR) and Pidilite Industries (PIDILITIND) are also likely to experience positive momentum, potentially leading to upward price movements if their bullish trends continue and key resistance levels are breached. This could provide short-term trading opportunities.

Traders should monitor the opening price and initial trading volumes for these stocks on Monday. Pay close attention to Sun Pharma's interaction with the 1960 resistance level and the ability of Dabur and Pidilite to sustain their bullish trends. Look for confirmation of breakouts or reversals at these critical junctures.

• •Sumeet Bagadia recommends three stocks to buy on Monday, May 18, 2026.
• •Sun Pharma is approaching 1960 resistance, supported by improving volumes.
• •Dabur and Pidilite Industries are experiencing bullish trends with potential for further gains.
• •Gains are contingent on maintaining key resistance levels.
• •Risk flag: Failure to breach resistance levels could lead to profit booking.